Citizen jury should consider aspirin prophylaxis

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7509.160-a (Published 14 July 2005) Cite this as: BMJ 2005;331:160
  1. Rachel T Iredale, senior lecturer (riredale@glam.ac.uk)
  1. University of Glamorgan, Pontypridd CF37 1DL

    EDITOR—I smiled to read that the jury was still out on aspirin to prevent cardiovascular disease in elderly people in This week in the BMJ because, of course, there has never been any sort of jury on this topic.12 This debate about aspirin has consumed the medical profession for over 30 years, yet almost no …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial